BioScrip to Host Analyst and Investor Day
November 26 2018 - 4:30PM
BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the
largest independent national provider of infusion and home care
management solutions, today announced that the Company will host an
Analyst and Investor Day on Thursday, December 6, 2018 in Reston,
Virginia.
Daniel E. Greenleaf, President and Chief
Executive Officer, will provide an update of the Company’s strategy
and business, followed by a fireside chat with members of
BioScrip’s executive management team. Presentations will
begin at 10:30 am ET and conclude between 12:00 pm and 12:30 pm
ET.
A live webcast of the event and copies of the
materials presented will be accessible via the Company's investor
relations website at https://investors.bioscrip.com/ or through the
following link:
https://event.webcasts.com/starthere.jsp?ei=1222421&tp_key=8818005a06.
Following management’s presentations, attendees
will tour one of BioScrip’s “Branches of the Future” in nearby
Chantilly, Virginia.
Attendance is by invitation only as space for
the event is limited. Institutional investors and analysts
interested in attending are encouraged to contact Kalle Ahl of The
Equity Group at 212-836-9614 or at kahl@equityny.com.
About BioScrip, Inc.
BioScrip, Inc. is the largest independent
national provider of infusion and home care management solutions,
with approximately 2,100 teammates and nearly 70 service locations
across the U.S. BioScrip partners with physicians, hospital
systems, payors, pharmaceutical manufacturers and skilled nursing
facilities to provide patients access to post-acute care services.
BioScrip operates with a commitment to bring customer-focused
pharmacy and related healthcare infusion therapy services into the
home or alternate-site setting. By collaborating with the full
spectrum of healthcare professionals and the patient, BioScrip
provides cost-effective care that is driven by clinical excellence,
customer service, and values that promote positive outcomes and an
enhanced quality of life for those it serves.
Investor Contacts:
Stephen Deitsch |
Kalle Ahl, CFA |
Chief Financial Officer
& Treasurer |
The Equity Group |
T: (720)
697-5200 |
T: (212)
836-9614 |
stephen.deitsch@bioscrip.com |
kahl@equityny.com |
BioPlus Acquisition (NASDAQ:BIOS)
Historical Stock Chart
From Aug 2024 to Sep 2024
BioPlus Acquisition (NASDAQ:BIOS)
Historical Stock Chart
From Sep 2023 to Sep 2024